l carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to Gut microbiota metabolism of l-carnitine
Gut microbiota metabolism of l carnitine and cardiovascular risk Atherosclerosis The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13





